{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:16:18Z","timestamp":1792516578439,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s13346-021-00958-x","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T12:03:01Z","timestamp":1617019381000},"page":"577-588","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction"],"prefix":"10.1007","volume":"12","author":[{"given":"Tausif","family":"Alam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Asif","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjula","family":"Baboota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5308-0655","authenticated-orcid":false,"given":"Javed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"key":"958_CR1","doi-asserted-by":"publisher","first-page":"96S","DOI":"10.1093\/ajh\/4.2.96S","volume":"4","author":"AJM Veld","year":"1991","unstructured":"Veld AJM. The place of isradipine in the treatment of hypertension. Am J Hypertens. 1991;4:96S-102S.","journal-title":"Am J Hypertens"},{"key":"958_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0939-6411(98)00015-0","volume":"46","author":"ML Verger","year":"1998","unstructured":"Verger ML, Fluckiger L, Kim Y, Hoffman M, Maincent P. Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur J Pharm Biopharm. 1998;46:137\u201343.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1\u20132","key":"958_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ijpharm.2014.08.017","volume":"474","author":"TT Tran","year":"2014","unstructured":"Tran TT, Tran PH, Nguyen MNU, Tran KTM, Pham MN, Tran PC, Vo TV. Amorphous isradipinenanosuspension by the sonoprecipitation method. Int J Pharm. 2014;474(1\u20132):146\u201350.","journal-title":"Int J Pharm"},{"issue":"5","key":"958_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3109\/03639045.2014.900081","volume":"41","author":"B Ramasahayam","year":"2015","unstructured":"Ramasahayam B, Eedara BB, Kandadi P, Jukanti R, Bandari S. Development of isradipine loaded self-nano emulsifying powders for improved oral delivery: in vitro and in vivo evaluation. Drug Dev Ind Pharm. 2015;41(5):753\u201363.","journal-title":"Drug Dev Ind Pharm"},{"key":"958_CR5","first-page":"1","volume":"1","author":"V Venugopal","year":"2016","unstructured":"Venugopal V, Kumar KJ, Muralidharan S, Parasuraman S, Raj PV, Kumar KV. Optimization and in vivo evaluation of isradipine nanoparticles using Box-Behnken design surface response methodology. Open Nan. 2016;1:1\u201315.","journal-title":"Open Nan"},{"key":"958_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.colsurfb.2017.11.064","volume":"162","author":"HA Fathi","year":"2017","unstructured":"Fathi HA, Allam A, Elsabahy M, Fetih G, El-Badry M. Nanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatin. Colloids Surf B Biointerfaces. 2017;162:236\u201345.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"958_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nrd2197","volume":"6","author":"CJH Porter","year":"2007","unstructured":"Porter CJH, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007;6:231\u201348.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"958_CR8","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1006\/bbrc.1994.2396","volume":"203","author":"E Lupo","year":"1994","unstructured":"Lupo E, Locher R, Weisser B, Vetter W. In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with \u03b1-tocopherol. Biochembiophys res commun. 1994;203(3):1803\u20138.","journal-title":"Biochembiophys res commun"},{"key":"958_CR9","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1098\/rstb.2005.1774","volume":"360","author":"T Godfraind","year":"2005","unstructured":"Godfraind T. Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis. Philos Trans R SocLond B BiolSci. 2005;360:2259\u201372.","journal-title":"Philos Trans R SocLond B BiolSci"},{"key":"958_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ijpharm.2019.03.056","volume":"563","author":"G Amasya","year":"2019","unstructured":"Amasya G, Aksu B, Badilli U, Onay-Besikci A, Tarimci N. QbD guided early pharmaceutical development study: production of lipid nanoparticles by high pressure homogenization for skin cancer treatment. Int J Pharm. 2019;563:110\u201321.","journal-title":"Int J Pharm"},{"issue":"2","key":"958_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1039\/C7NR07736J","volume":"10","author":"N Shrestha","year":"2018","unstructured":"Shrestha N, Bouttefeux O, Vanvarenberg K, Lundquist P, Cunarro J, Tovar S, Khodus G, Andersson E, Keita AV, Dieguez CG, Artursson P, Preat V, Beloqui A. Stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers. Nanoscale. 2018;10(2):603\u201313.","journal-title":"Nanoscale"},{"key":"958_CR12","doi-asserted-by":"crossref","unstructured":"Shete H, Patravale V. Long chain lipid based tamoxifen NLCS. Part I: preformulation studies, formulation development and physicochemical characterization. Int J Pharm. 2013;454:573\u2013584.","DOI":"10.1016\/j.ijpharm.2013.03.034"},{"key":"958_CR13","doi-asserted-by":"crossref","unstructured":"D\u2019Souza S, Faraj JA, Giovagnoli S, DeLuca PP. IVIVC from long acting olanzapine microsphere. Int J Biomat. 2014;1\u201312.","DOI":"10.1155\/2014\/407065"},{"issue":"1","key":"958_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/21691401.2016.1138486","volume":"45","author":"GR Qadri","year":"2017","unstructured":"Qadri GR, Ahad A, Aqil M. Invasomes of isradipine for enhanced transdermal delivery against hypertension: formulation, characterization, and in vivo pharmacodynamic study. Artif cells nanomedbiotechnol. 2017;45(1):139\u201345.","journal-title":"Artif cells nanomedbiotechnol"},{"issue":"2","key":"958_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351\u20138.","journal-title":"Anal Biochem"},{"key":"958_CR16","doi-asserted-by":"crossref","unstructured":"Pogodina M, Shornikova YS, Chentsov luS. Electron microscopy description of cardiomyocytes from the left ventricle of rat heart after apoptosis induction by isoproterenol. Biol Bull. 2006;33(1):19\u201329.","DOI":"10.1134\/S1062359006010031"},{"key":"958_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.colsurfb.2017.03.006","volume":"154","author":"V Kaithwas","year":"2017","unstructured":"Kaithwas V, Dora CP, Kushwah V, Jain S. Nanostructured lipid carriers of olmesartanmedoxomilwithenhanced oral bioavailability. Colloids Surf B Biointerfaces. 2017;154:10\u201320.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"11","key":"958_CR18","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1016\/j.xphs.2018.07.021","volume":"107","author":"T Alam","year":"2018","unstructured":"Alam T, Khan S, Gaba B, Haider MF, Baboota S, Ali J. Adaptation of quality by design-based development of isradipinenanostructurede lipid carrier and its evaluation for in vitro gut permeation and in vivo solubilization fate. J Pharm Sci. 2018;107(11):2914\u201326.","journal-title":"J Pharm Sci"},{"key":"958_CR19","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.msec.2012.04.017","volume":"32","author":"P Severino","year":"2012","unstructured":"Severino P, Santana MHA, Souto EB. Optimizing SLN and NLCS by 22 full factorial design: effect of homogenization technique. Mater SciEng C. 2012;32:1375\u20139.","journal-title":"Mater SciEng C"},{"key":"958_CR20","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ejps.2009.04.008","volume":"37","author":"RK Subedi","year":"2009","unstructured":"Subedi RK, Kang KW, Choi HK. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur J Pharm Sci. 2009;37:508\u201313.","journal-title":"Eur J Pharm Sci"},{"key":"958_CR21","first-page":"37","volume":"33","author":"B Shah","year":"2016","unstructured":"Shah B, Khunt D, Bhatt H, Misra M, Padh H. Intranasal delivery of venlafaxine loaded nanostructured lipid carrier: risk assessment and QbD based optimization. J Drug DelivSciTechnol. 2016;33:37\u201350.","journal-title":"J Drug DelivSciTechnol"},{"key":"958_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ijbiomac.2018.01.121","volume":"110","author":"N Jawahar","year":"2018","unstructured":"Jawahar N, Hingarh PK, Arun R, Selvaraj J, Anbarasan A, Sathianarayanan S, Nagaraju G. Enhanced oral bioavailability of an antipsychotic drug through nanostructured lipid carriers. Int J BiolMacromol. 2018;110:269\u201375.","journal-title":"Int J BiolMacromol"},{"key":"958_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jsps.2015.03.008","volume":"24","author":"Z Attari","year":"2016","unstructured":"Attari Z, Bhandari A, Jagadish PC, Lewis S. Enhanced ex vivo intestinal absorption of olmesartanmedoxomilnanosuspension: preparation by combinative technology. Saudi Pharm J. 2016;24:57\u201363.","journal-title":"Saudi Pharm J"},{"key":"958_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ijpharm.2011.05.044","volume":"415","author":"R Tiwari","year":"2011","unstructured":"Tiwari R, Pathak K. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int Pharm. 2011;415:232\u201343.","journal-title":"Int Pharm"},{"key":"958_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ejpb.2016.10.011","volume":"109","author":"S Khan","year":"2016","unstructured":"Khan S, Shaharyar M, Fazil M, Hassan MQ, Baboota S, Ali J. Tacrolimus-loaded nanostructured lipid carriers for oral delivery-in vivo bioavailability enhancement. Eur J Pharm Biopharm. 2016;109:149\u201357.","journal-title":"Eur J Pharm Biopharm"},{"key":"958_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.colsurfa.2014.11.015","volume":"466","author":"J Luan","year":"2015","unstructured":"Luan J, Zheng F, Yang X, Yu A, Zhai G. Nanostructured lipid carriers for oral delivery of baicalin: in vitro and in vivo evaluation. Colloids and Surfaces A: PhysicochemEng Aspects. 2015;466:154\u20139.","journal-title":"Colloids and Surfaces A: PhysicochemEng Aspects"},{"key":"958_CR27","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.nbd.2011.04.007","volume":"43","author":"E Ilijic","year":"2011","unstructured":"Ilijic E, Guzman JN, Surmeier DJ. The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson\u2019s disease. Neurobiol Dis. 2011;43:364\u201371.","journal-title":"Neurobiol Dis"},{"key":"958_CR28","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.biopha.2018.10.199","volume":"109","author":"MA Ansari","year":"2019","unstructured":"Ansari MA, Iqubal A, Ekbbal R, Haque SE. Effects of nimodipine, vinpocetine and their combination on isoproterenol induced myocardial infarction in rats. Biomed Pharmacother. 2019;109:1372\u201380.","journal-title":"Biomed Pharmacother"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-021-00958-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-021-00958-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-021-00958-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T10:59:15Z","timestamp":1643281155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-021-00958-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["958"],"URL":"https:\/\/doi.org\/10.1007\/s13346-021-00958-x","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,29]]},"assertion":[{"value":"4 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"I, Dr. Javed Ali, corresponding author of this research article on behalf of all the authors (Mr. Tausif Alam, Mr. Asif Ansari, Dr. Sanjula Baboota) hereby confirm that this article is original, does not infringe on any copyright, is not under consideration by any other journal, and has not been previously published. Ethical approval for conducting experiment on animals has been sought and obtained as necessary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}